Targeted Medical Pharma Inc  

(Public, OTCMKTS:TRGM)   Watch this stock  
Find more results for J Gintz
0.810
0.000 (0.00%)
Jul 18 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.49 - 1.39
Open     -
Vol / Avg. 0.00/16,360.00
Mkt cap 21.40M
P/E     -
Div/yield     -
EPS -0.42
Shares 26.42M
Beta     -
Inst. own 0%

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -54.11% -97.72%
Operating margin -39.47% -40.20%
EBITD margin - -35.89%
Return on average assets -81.62% -119.51%
Return on average equity - -
Employees 57 -
CDP Score - -

Address

Suite 301 2980 Beverly Glen Circle
LOS ANGELES, CA 90077
United States - Map
+1-310-4749809 (Phone)
+1-310-5317089 (Fax)

Website links

Description

Targeted Medical Pharma, Inc. doing business as Physician Therapeutics (PTL), is a specialty pharmaceutical company that develops and commercializes nutrient-based and pharmaceutical-based therapeutic systems. The Company develops and sells a line of patented prescription medical food products that are sold in the United States through a network of distributors and directly to physicians who dispense medical foods and other pharmaceutical products through their office practices. Itstechnology uses a five component system to allow uptake and use of important neurotransmitter precursors to produce the neurotransmitters that control autonomic nervous system function such as sleep and pain perception. The neurotransmitters addressed by its patents include nitric oxide, acetylcholine, serotonin, norepinephrine, epinephrine, dopamine and histamine.

Officers and directors

David Samuel Silver M.D. President, Chief Operating Officer, Director
Age: 47
William E. Shell M.D. Chief Executive Officer, Chief Scientific Officer, Director
Age: 70
William B. Horne Chief Financial Officer
Age: 42
Kim Giffoni Executive Vice President - Foreign Sales and Investor Relations, Director
Age: 61
Douglas Gintz Chief Technology and Information Officer
Amir R. Blachman Chief Compliance and Ethics Officer, Vice President - Operations and Strategy, Corporate Secretary
Age: 41
Maurice J. DeWald Non-Executive Independent Chairman of the Board
Age: 74
Thomas Wenkart Director
Arthur R. Nemiroff Independent Director
Age: 70
Paul Pelosi Jr. Independent Director